India Develops New Antibiotic for Pneumonia:
Respiratory problems are considered an additional pressure on the health sector. People of all ages are at risk of diseases like asthma, bronchitis and pneumonia, which can lead to serious health problems if not taken care of. Pneumonia is a serious disease due to which millions of people die every year. This infection in the lungs causes serious health problems. The risk of this disease is highest in children.
India has prepared indigenous antibiotic for pneumonia
India has achieved great success in the treatment of this disease. India has found a cure for an infection called Community-Acquired Bacterial Pneumonia (CABP). Scientists have prepared the first indigenous antibiotic drug 'Nepithromycin', which can reduce the infection with three doses. Union Minister Dr. Jitendra Singh officially announced this success of India.
Risk of death in children due to pneumonia
According to World Health Organization reports, pneumonia is the leading cause of death in children worldwide. More than 7.25 lakh children under the age of five die every year due to pneumonia, including about 1.90 lakh newborns. The risk of this disease is also higher in the elderly. Doctors say that this disease can be caused by any bacteria, virus or fungus.
Antibiotics for pneumonia
The antibiotic nefithromycin has been developed in collaboration with the Biotechnology Industry Research Assistance Council (BIRAC). It is the country's first indigenously developed antibiotic aimed at combating antimicrobial resistance.
The drug will be given once a day for three days to CABP patients. Several clinical trials have been conducted on this drug in the past 15 years. These include phase I and II trials conducted in the US and Europe. The drug recently completed its Phase III trial in India.
Benefits of the drug
- 10 times more effective than azithromycin
- Stays in the lungs for eight times longer
- The course will be completed in three days with one pill per day
- The risk of antibiotic misuse will be reduced
- The treatment will be shorter, easier and more effective
- Safer and less side effects on patients
- You will not have to stay in hospitals for long.
Tags: India-s-first-indigenous-antibiotic, nafithromycin, swadeshi-antibiotic, pneumonia
0 Comments